Case Reports in Hematology / 2022 / Article / Tab 1 / Case Report
Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone Table 1 Laboratory data on admission.
Complete Blood Count Biochemistry test Serological test WBC 5,900/μl TP 7.8 g/dl C3 79 mg/dl Banded neutrophil 1.0% Alb 3.5 g/dl C4 23 mg/dl Segmented neutrophil 84.0% AST 14 U/l ANA 40 fold Lymphocyte 4.0% ALT 5 U/l RF 6 IU/ml Monocyte 3.0% ALP 270 IU/ml BNP 73 pg/ml Eosinophil 8.0% γ -GTP16 IU/l HCV Ab (−) RBC 426 x 104 /μl CHE 186 U/L HBs Ag (−) Hb 12.5 g/dl LDH 208 U/l IgG 546 mg/dl Ht 37.5% T-bil 0.6 mg/dl IgA 662 mg/dl MCV 88.0 fl BUN 22.5 mg/dl IgM 1272 mg/dl Plt 24.6 × 104 /μl Cr 1.66 mg/dl sIL-2R 3190 U/ml UA 3.9 mg/dl Urinalysis T-CHO 166 mg/dl Coagulation Color Yellow TG 80 mg/dl PT-INR 0.96 Protein 1(+) Glu 109 mg/dl APTT 33.4 sec Glucose (−) HbA1c 5.3% Fibrinogen 294.6 mg/dl Occult blood (+/−) Na 137 mEq/l FDP 6.5 μ g/ml K 3.5 mEq/l D-dimer 3.0 μ g/ml Cl 102 mEq/l CRP 0.17 mg/dl